Skip Navigation

U.S. Flag

Print Print   Download Reader Download   Text Enlarge text size Reduce text size Normal text size

Go to Text Version

HHS Recovery Act Recipient Reporting Readiness Tool

Step 4. Review and Copy the Grant Awards Data

TAGGS provides some – but not all – of the data needed for the Recipient Report. Recipients are responsible for directly collecting and reporting all required data to FederalReporting.gov. Data that HHS does not currently collect are highlighted in yellow. Do not copy this highlighted information. Please enter the appropriate data for your organization in these required fields. For assistance with entering these data please contact FederalReporting.gov.

You may capture the data HHS does provide by copying data from this screen and pasting it into the reporting format of your choice, such as the Excel spreadsheet template, the XML template, or by logging into the online form. For assistance with copying and pasting these data please e-mail our help desk at Readiness Help.

 

Award Detail for: DEVELOPMENT OF BIOMATERIALS THAT RELEASE THERAPEUTIC AGENTS TO MODULATE INFLAMMAT
MICHIGAN TECHNOLOGICAL UNIVERSITY
DUNS Number: 065453268
1400 TOWNSEND DRIVE
HOUGHTON, MI 49931-1200
Recipient Report: Grant or Loan
Prime Recipient

Reporting Information
Award Type Award Number Final Report
Grant 5R21NS062392-02 Recipient responsible for this data

Award Recipient Information
Recipient DUNS Number Recipient Account Number Recipient Congressional District
065453268 Recipient responsible for this data 1

Award Information
Funding Agency Code Awarding Agency Code Award Date
7529 7529 03-24-2010
Amount of Award Sub Account Number for Program Source (TAS)  
$ 3,462 Recipient responsible for this data
Program Source (TAS)* CFDA Number 
750901 93.701
Total Number of Sub Awards to Individuals Total Amount of Sub Awards to Individuals
Recipient responsible for this data Recipient responsible for this data
Total Number of Payments to Vendors less than $25,000/award Total Amount of Payments to Vendors less than $25,000/award
Recipient responsible for this data Recipient responsible for this data
Total Number of Sub Awards less than $25,000/award Total Amount of Sub Awards less than $25,000/award
Recipient responsible for this data Recipient responsible for this data
Award Description
DESCRIPTION (provided by applicant): The goal of this study is to develop new technology to reduce secondary injury following spinal cord injury. Currently, there are no viable treatments for patients who have sustained spinal cord injury. Clinically, interventions involve injection of agent intravenously. Experimentally, most interventions involve injection of agent intravenously or intraperiotoneally. Although these treatments have improved functionality, technology has not yet been developed to supply continuous delivery of agents to the damaged site without the need of pumps or through the administration of several injections. Here, we present a novel biomaterial blend composed of agarose and methylcellulose. Prior preliminary data has shown that these blends exist as a liquid at room temperature and quickly solidify at physiological temperatures. They are injectable through a syringe for ease of application to an injured site. Within this revised application, we present data showing that glutathione and interleukin-10 can be released for five and six days in vitro respectively. The hydrogel is fabricated in a chilled environment using just aqueous buffers. Thus, loaded agents are not subjected to harsh processing conditions and should be functional after release. Data shows that released glutathione is able to protect dissociated chick DRG neurons from free radicals produced by the Fenton reaction. Also, interleukin-10 released from the hydrogel was detected by an interleukin-10 ELISA. A pilot study was conducted where hydrogel loaded with interleukin-10 and glutathione were injected into a rat spinal cord injury model. Preliminary data show that hydrogel loaded with therapeutics had higher BBB scores 42 days post-injury compared to those injected with just plain hydrogel. In aim one of this proposal; techniques are described to couple the fluorescent chemical rhodomine to both glutathione and interleukin-10. Fluorescent conjugation will also be confirmed in aim 1. In aim two; the proposal overviews a collaborative research experience with Dr. Phillip Popovich at Ohio State. Hydrogels developed will then be applied to a rat spinal cord injury model developed at Ohio State. Work there will determine the acute in vivo release of therapeutic, acute and chronic mitigation of the inflammatory response, chronic assessment of lesion volume and neuronal sparing, and chronic assessment of locomotor recovery. PUBLIC HEALTH RELEVANCE: Current techniques to administer agents to reduce secondary injury following spinal cord trauma involve intravenous or intraperiotoneally injection. Using biomaterials, hydrogels made from agarose and methylcellulose can be loaded with agents that reduce secondary injury for a sustained period of time. The research described in this proposal will determine if hydrogels loaded with glutathione or interleukin-10 are more effective at reducing secondary injury than injection of these agents in a rat spinal cord injury model.

Project Information
Project Name or
Project/Program Title
Project Status Total Federal Amount ARRA Funds
Received/Invoiced
DEVELOPMENT OF BIOMATERIALS THAT RELEASE THERAPEUTIC AGENTS TO MODULATE INFLAMMAT Recipient responsible for this data Recipient responsible for this data
Number of Jobs Description of Jobs Created
Recipient responsible for this data Recipient responsible for this data
Quarterly Activities/Project Description
Recipient responsible for this data
 
Activity Code (NAICS or NTEE-NPC)
1Recipient responsible for this data2Recipient responsible for this data
3Recipient responsible for this data4Recipient responsible for this data
5Recipient responsible for this data6Recipient responsible for this data
7Recipient responsible for this data8Recipient responsible for this data
9Recipient responsible for this data10Recipient responsible for this data
Total Federal Amount of ARRA
Expenditure
Total Federal ARRA
Infrastructure Expenditure
Infrastructure Contact Name
Recipient responsible for this data Recipient responsible for this data Recipient responsible for this data
Infrastructure Contact Email Infrastructure Contact Phone Infrastructure Contact Phone Ext.
Recipient responsible for this data Recipient responsible for this data Recipient responsible for this data
Infrastructure Contact Street Address 1 Infrastructure Contact Street Address 2 Infrastructure Contact Street Address 3
1400 TOWNSEND DRIVE Not Available Recipient responsible for this data
Infrastructure City Infrastructure State Infrastructure ZIP Code+4
HOUGHTON MI 49931-1200
Infrastructure Purpose and Rationale
Recipient responsible for this data

Primary Place of Performance
Street Address 1 Street Address 2 City
110 8TH STREET Recipient responsible for this data TROY
State Zip Code+4 Congressional District
NY 121803590 1
Country  
US

Recipient Highly Compensated Officers
Prime Recipient Indication of Reporting Applicability # Officer Name Officer Compensation
Recipient responsible for this data 1 Recipient responsible for this data Recipient responsible for this data
2 Recipient responsible for this data Recipient responsible for this data
3 Recipient responsible for this data Recipient responsible for this data
4 Recipient responsible for this data Recipient responsible for this data
5 Recipient responsible for this data Recipient responsible for this data

This concludes the current search.
To begin a new search, return to the HHS Recovery Act Recipient Reporting Readiness Tool.

USE IN THE RECIPIENT REPORT

The information provided by this tool is baseline data that the Recipient should include in the Recipient Report that must be submitted to FederalReporting.gov beginning October 1, 2009. The data from this tool can be cut and pasted directly into the Recipient Report.